| Jordan J Moen, DPT, OCS | |
|
1400 Madison Ave Ste 100aa, Mankato, MN 56001-5465 | |
| (507) 385-2600 | |
| Not Available |
| Full Name | Jordan J Moen |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 13 Years |
| Location | 1400 Madison Ave Ste 100aa, Mankato, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083991558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 8819 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southwest Minnesota Region | 4688585771 | 533 |
News Archive
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Both fine-particle air pollution and noise pollution may increase a person's risk of developing cardiovascular disease, according to German researchers who have conducted a large population study, in which both factors were considered simultaneously.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
The transfusion of red blood cells is a common treatment in clinical practice. However, the level at which they are transfused varies based not only on a patient's health, but also is determined by what the administering physician deems appropriate. Today, the American Association of Blood Banks (AABB) has issued new guidelines, published in Annals of Internal Medicine, recommending that transfusion of red blood cells be considered at a hemoglobin threshold of 7 to 8 g/dL for stable adults and children.
› Verified 2 days ago
| Provider Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Both fine-particle air pollution and noise pollution may increase a person's risk of developing cardiovascular disease, according to German researchers who have conducted a large population study, in which both factors were considered simultaneously.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
The transfusion of red blood cells is a common treatment in clinical practice. However, the level at which they are transfused varies based not only on a patient's health, but also is determined by what the administering physician deems appropriate. Today, the American Association of Blood Banks (AABB) has issued new guidelines, published in Annals of Internal Medicine, recommending that transfusion of red blood cells be considered at a hemoglobin threshold of 7 to 8 g/dL for stable adults and children.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan J Moen, DPT, OCS 1400 Madison Ave Ste 100aa, Mankato, MN 56001-5465 Ph: (507) 385-2600 | Jordan J Moen, DPT, OCS 1400 Madison Ave Ste 100aa, Mankato, MN 56001-5465 Ph: (507) 385-2600 |
News Archive
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
Both fine-particle air pollution and noise pollution may increase a person's risk of developing cardiovascular disease, according to German researchers who have conducted a large population study, in which both factors were considered simultaneously.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
The transfusion of red blood cells is a common treatment in clinical practice. However, the level at which they are transfused varies based not only on a patient's health, but also is determined by what the administering physician deems appropriate. Today, the American Association of Blood Banks (AABB) has issued new guidelines, published in Annals of Internal Medicine, recommending that transfusion of red blood cells be considered at a hemoglobin threshold of 7 to 8 g/dL for stable adults and children.
› Verified 2 days ago
Ms. Francanne M Etringer, SSND,PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 170 Good Counsel Dr, Mankato, MN 56001 Phone: 504-452-4184 | |
Rhea Atherton, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-386-2600 | |
Nancy D Dobson, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 St. Andrews Court, Suite 310, Mankato, MN 56001 Phone: 507-388-5437 Fax: 507-388-2108 | |
Prentice Valvick, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 708 Mound Ave, Mankato, MN 56001 Phone: 507-385-4300 | |
Jacob Nienow, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1230 E Main St, Mankato, MN 56001 Phone: 507-625-1811 | |
Kimberly K Devine-johnson, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 St. Andrews Court, Suite 310, Mankato, MN 56001 Phone: 507-388-5437 Fax: 507-388-2108 |